TATVA CHINTAN PHARMA CHEM
Back to Balance Sheet
|
TATVA CHINTAN PHARMA CHEM Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹236 Cr | ₹171 Cr | ₹128 Cr | ₹88 Cr | ₹73 Cr |
What is the latest Total Current Liabilities ratio of TATVA CHINTAN PHARMA CHEM ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹236 Cr |
Mar2022 | ₹171 Cr |
Mar2021 | ₹128 Cr |
Mar2020 | ₹88 Cr |
Mar2019 | ₹73 Cr |
How is Total Current Liabilities of TATVA CHINTAN PHARMA CHEM Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹236 Cr | 37.93 | |
Mar2022 | ₹171 Cr | 33.32 | |
Mar2021 | ₹128 Cr | 46.50 | |
Mar2020 | ₹88 Cr | 20.64 | |
Mar2019 | ₹73 Cr | - |
Compare Total Current Liabilities of peers of TATVA CHINTAN PHARMA CHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TATVA CHINTAN PHARMA CHEM | ₹2,871.2 Cr | -1.4% | 13.7% | -27% | Stock Analytics | |
PIDILITE INDUSTRIES | ₹152,013.0 Cr | 2.4% | -0.9% | 27.6% | Stock Analytics | |
SOLAR INDUSTRIES INDIA | ₹80,217.6 Cr | 0.8% | 0.9% | 137.2% | Stock Analytics | |
SRF | ₹79,083.2 Cr | 1.1% | 4.3% | 5% | Stock Analytics | |
GUJARAT FLUOROCHEMICALS | ₹39,882.1 Cr | -0.7% | 17.2% | 8.1% | Stock Analytics | |
DEEPAK NITRITE | ₹33,805.0 Cr | 2.3% | 16.8% | 30.5% | Stock Analytics |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TATVA CHINTAN PHARMA CHEM | -1.4% |
13.7% |
-27% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses